A leading Chinese vaccine has been found to be 50.4 percent effective, according to the results of a late-stage trial in Brazil, serving a blow to the Chinese regime as it seeks to leverage the vaccine to bolster its global image. The results from Brazil’s state-funded Butantan Institute on Tuesday were just enough to pass…
Brazil Finds Chinese Vaccine to Be 50.4% Effective, Far Lower Than Initial Claims
Chinese Vaccine Found to Be 50.4 Percent Effective in Brazil Trial
A leading Chinese COVID-19 vaccine candidate has been found to be 50.4 percent effective, according to the results of a late-stage trial in Brazil, a potential setback to the Chinese regime as it seeks to leverage the vaccine to boost its global image. The results from Brazil’s state-funded Butantan Institute on Jan. 12 were just…
Chinese COVID-19 Vaccine Shows 50.4 Percent Efficacy in Brazil Trial
A leading Chinese COVID-19 vaccine candidate has been found to be 50.4 percent effective, according to the results of a late-stage trial in Brazil, a potential setback to the Chinese regime as it seeks to leverage the vaccine to boost its global image. The results from Brazil’s state-funded Butantan Institute on Jan. 12 were just…
China Insider: Sinovac Delays Release of Vaccine Trials, Effectiveness Questioned
Chinese company Sinovac Biotech Ltd. is delaying the release of the results of a phase III clinical trial of its CCP virus vaccine until January. Before that, Sinovac had delayed its announcement twice, which raised questions about the effectiveness of the vaccine.
Beijing Mandates Millions to Get China-Made COVID-19 Vaccine as Testing Continues
The Chinese regime recently mandated that 50 million doses of COVID-19 vaccines must be administered to people designated as high-risk by Feb. 15, 2021—although drug companies have not yet completed testing and the vaccines have yet to be approved by regulators. Meanwhile, Fosun Pharmaceutical announced that it ordered 100 million doses of the COVID-19 vaccine…
Beijing Mandates Millions Must Get China-Made COVID-19 Vaccine as Testing Continues
The Chinese regime recently mandated that 50 million doses of COVID-19 vaccines must be administered to people designated as high risk by Feb. 15, 2021—although drug companies have yet to complete testing and the vaccines have yet to be approved by regulators. Meanwhile, Fosun Pharmaceutical announced that it had ordered 100 million doses of the…
-
Recent Posts
-
Archives
- May 2025
- April 2025
- July 2023
- June 2023
- May 2023
- April 2023
- March 2023
- February 2023
- January 2023
- December 2022
- November 2022
- October 2022
- September 2022
- August 2022
- July 2022
- June 2022
- May 2022
- April 2022
- March 2022
- February 2022
- January 2022
- December 2021
- November 2021
- October 2021
- September 2021
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- January 2021
- December 2020
- September 2013
- July 2013
- March 2013
- January 2013
- December 2012
- November 2012
- December 1
-
Meta